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An Appropriate Legislative Response to
Cloning for Biomedical Research:
The Case Against a Criminal Ban
Adam Gusman*
"All truth passes through three stages. First, it is ridiculed. Second, it is
violently opposed. Third, it is accepted as being self-evident."
Arthur Schopenhauer, 1788-1860
INTRODUCTION
The announcement by British scientists in 1997 that they had
successfully cloned a sheep sparked an immediate reaction of shock and
alarm. The legislative and executive branches of the federal government
responded rapidly. President Clinton ordered the National Bioethics
Advisory Commission (NBAC) to study the ethical implications of cloning
human beings. Individual states began passing laws that prohibited human
cloning, enforced through civil or criminal penalties.1  A "crisis
atmosphere" prevailed in Congress, where the Senate majority leader tried
to move an anti-cloning bill directly to the Senate floor without hearings
less than 48 hours after its presentation.2 Several proposals for federal
cloning legislation were introduced, but so far none have passed.3
* Adam Gusman is an associate at Winston & Strawn's Chicago office. He received a B.A.
from the University of North Carolina and a J.D. cum laude from Georgetown University
Law Center. Please address all correspondence to agusman@winston.com.
1. HuMAN CLONING: SCIENCE, ETHics, AND PUBLIC POLICY 118 (Barbara MacKinnon
ed., University of Illinois Press 2000).
2. Id.
3. Recent proposals for legislative action have included the following: Human Cloning
Prohibition Act of 2002, S. 2439, 107th Cong. (2002); Human Cloning Prohibition Act of
2001, S. 1758, 107th Cong. (2001); Human Cloning Prohibition Act of 2001, S. 1899, 107th
Cong. (2001) (passed by the House on July 31, 2001, but not taken up by the Senate). Each
bill would have made it a crime to clone human beings, but differed significantly on other
issues, such as cloning for biomedical research. To some extent, this flurry of legislative
activity has continued to the present day at the state level. In 2003, sixty-nine cloning bills
were introduced by state legislatures in twenty-eight different states (though only four were
enacted). See National Conference of State Legislatures website, available at
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The current political climate condemns reproductive cloning.4  At
present, the procedure cannot guarantee the viability of the clone and there
is a fairly widespread moral consensus that it would be unacceptable to
clone a human being even if it was safe. 5 Several states have prohibited
human reproductive cloning, and some have also banned therapeutic
cloning.6 By contrast, other states have carved out exceptions that permit
research using nuclear transplantation as long as the research will not result
in a human being.7 The question this Note asks, and attempts to answer, is
one posed by the Senate Appropriations Committee in 2002: "must we
http://www.ncsl.org.
4. See June Mary Zekan Makdisi, The Slide from Human Embryonic Stem Cell Research
to Reproductive Cloning: Ethical Decision-making and the Ban on Federal Funding, 34
RUTGERS L.J. 463,465 (2003).
5. Several bioethics commissions have reached this conclusion. For example, the
National Bioethics Advisory Commission determined that "any attempt to clone human
beings via somatic cell nuclear transfer techniques is uncertain in its prospects, is
unacceptably dangerous to the fetus and, therefore, morally unacceptable." The National
Bioethics Advisory Commission, Cloning Human Beings: Report and Recommendations
(June 1997), available at http://www.bioethics.gov/reports/past-commissions/
nbac cloning.pdf (last visited Aug. 12, 2004). Even the American Association for the
Advancement of Science endorses a ban on "efforts to implant a human cloned embryo for
the purpose of reproduction" based on the risks identified in animal studies. Am. Ass'n for
the Advancement of Science, Statement on Human Cloning (Apr. 10, 2002), available at
http://www.aaas.org/news/releases/2002/Cloning.shtml (last visited Aug. 12, 2004).
6. In its report, the President's Council on Bioethics abandoned the ambiguity of the
terms "reproductive cloning" and "therapeutic cloning," instead referring to "cloning-to-
produce-children" and "cloning-for-biomedical-research," respectively. The President's
Council on Bioethics, Human Cloning and Human Dignity: An Ethical Inquiry (July 2002)
[hereinafter The President's Council on Bioethics], available at www.bioethics.gov/
reports/cloningreport/index.html (last visited Aug. 12, 2004). Simply because the latter
terms are unwieldy, this paper will continue to refer to reproductive cloning and therapeutic
cloning throughout, despite the potential for some ambiguity.
7. The legislatures in Iowa, Michigan, North Dakota, and Arkansas have passed total
bans on human cloning, both reproductive and therapeutic. See http://www.ncsl.org/
programs/health/genetics/rt-shel.htm. By contrast, Rhode Island, California, Louisiana, and
Virginia prohibit reproductive cloning but carve out an exception that allows therapeutic
cloning to proceed. Id. Perhaps most importantly, some policymakers view therapeutic
cloning as the first step on a slippery slope that will eventually lead to reproductive cloning.
Additionally, some state statutes may implicitly prohibit nuclear transplantation techniques
even though they may not explicitly mention cloning for biomedical research. South
Dakota's law prohibiting the use or destruction of embryos for research purposes is an
example, though it appears to be fairly unique. See S.D. CODIFIED LAWS § 34-14-16 (Michie
2004) ("No person may knowingly conduct nontherapeutic research that destroys a human
embryo."); § 34-14-17 ("No person may knowingly conduct nontherapeutic research that
subjects a human embryo to substantial risk of injury or death. No person may sell or
transfer a human embryo with the knowledge that the embryo will be subjected to
nontherapeutic research."). Cloning for biomedical research is considered "nontherapeutic
research" because it is not "intended to help preserve the life and health of the particular
embryo subjected to risk." § 34-14-19.
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sacrifice medical research in the name of a total [cloning] ban?" 8
Legislatures have addressed the issue of therapeutic cloning in a number
of ways including regulation, voluntary moratoria, self-enforcement among
the scientific community, and legislative bans. Many people believe that
the process of therapeutic cloning, in which embryos are destroyed, is so
unethical and the possible misuse of the resulting cloned embryos so
threatening, that cloning for biomedical research should be criminalized.
The central ethical issue is that embryos created through this method are
discarded when they are no longer useful for research. Some also object
that the embryos are created for the sole purpose of research and are never
intended to develop into a person.9 Others are concerned that if therapeutic
cloning is permitted, than it is just a matter of time before human beings are
cloned as well. 10
It is worth noting that a criminal ban on the practice of cloning human
embryos - regardless of whether a scientist intends to create a human being
- is the most restrictive of all potential legislative policies, yet several states
have already adopted this approach and Congress has considered enacting
such laws." Some states, however, have placed a criminal ban on
reproductive cloning while allowing therapeutic cloning to proceed, albeit
without public funding.' 2  In theory, legislatures could not only permit
therapeutic cloning to proceed without threat of criminal sanction, but also
fund, and perhaps even encourage, the research.13 Such a debate currently
8. Human Cloning: Must We Sacrifice Medical Research in the Name of a Total Ban?:
Hearing Before the Senate Comm. on the Judiciary, 107th Cong. (Jan. 24 and Mar. 12,
2002), available at http://www.access.gpo.gov/congress/senate (last visited Aug. 10, 2004).
9. There are other ethical considerations in therapeutic cloning and stem cell research
that are beyond the scope of this Note, most notably ensuring that the egg donors who
provide the raw material for cloning do so only upon informed consent. See R.M. Green et
al., Overseeing Research on Therapeutic Cloning: A Private Ethics Board Responds to Its
Critics, HASTINGS CENTER REP. 27, 30 (May-June 2002). Even if therapeutic cloning is
allowed to proceed legally, the scientific community must continue to ensure its ethical
practice. Id. at 32.
10. Id. at28.
11. On February 27, 2003, the House passed by an overwhelming vote of 241 to 155 the
Human Cloning Prohibition Act of 2003 (S. 245), but it stalled in the Senate. If passed into
legislation, this Act would have banned both types of cloning, and it also would make it a
crime to "receive or import a cloned human embryo or any product derived from a cloned
human embryo," punishable by ten years in prison and fines of $1 million. Wendy Lim,
Towards Developing a Natural Law Jurisprudence in the U.S. Patent System, 19 SANTA
CLARA COMPUTER & HIGH TECH. L.J. 559, 612 (2003).
12. See National Conference of State Legislatures website, at http://www.ncsl.org/
programs/health/Genetic/rt-shcl.htm (last visited Aug. 12, 2004).
13. In fact, this is precisely what the California legislature has done, though there
appears to be virtually no chance of adopting this stance as federal policy, given Congress'
reluctance to fund any embryo research. See infra notes 103-108.
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rages over whether stem cell research should receive federal funding.' 4
Interestingly, the debate in this context is not over whether stem cell
research will be criminally banned, but whether it will receive public
funding.
Determining the best public policy for this potential research requires
tackling the ethical issues and practical drawbacks presented by therapeutic
cloning. In order to provide a scientific background, Part I of this Note will
briefly outline the processes by which nuclear transplantation and the
subsequent derivation of stem cells occur in the laboratory. Part II will
argue that because of the American tradition of scientific inquiry free from
governmental prohibition, as a matter of policy, those who would
criminalize this area of research bear the burden of showing why a criminal
ban would benefit society. In order to weigh the costs and benefits of
therapeutic cloning from a policy standpoint, Part III will examine the
potential benefits of embryonic stem cells, particularly those derived from
cloned embryos, while Part IV will examine some of the arguments put
forth by those who would make therapeutic cloning a crime. Part V will
discuss when it is proper to invoke the criminal law to enforce moral views,
ultimately concluding that criminal sanctions are particularly ill-suited to
therapeutic cloning. This Note concludes that, despite the ethical concerns
legitimately raised in response to therapeutic cloning, legislatures should
not criminalize the practice at this point. Finally, Part VI will offer less
restrictive policy alternatives that could still provide necessary oversight of
this controversial research.
I. THE SCIENCE OF NUCLEAR TRANSPLANTATION AND STEM CELLS
The scientific phrase for the process of embryo "cloning" is somatic cell
nuclear transfer, or "nuclear transplantation" for short. 15 It is accomplished
by transferring the DNA from a human adult cell nucleus into the
cytoplasm of an oocyte (egg) whose own nucleus has been removed.16 The
fertilized egg is then induced by an electrical charge to begin dividing.
17
Nuclear transplantation is the initial step in deriving embryonic stem cells
for eventual treatment of patients (therapeutic cloning), or in potentially
14 President Bush announced his decision that federal funds may be used for research on stem
cell lines that existed as of August 9, 2001. Press Release, The White House, Office of the
Press Secretary, Remarks by the President on Stem Cell Research (Aug. 9, 2001) (available
at http://www.whitehouse.gov/news/releases/2001/08/20010809-2.html).
15. IAN WILMUT ET AL., THE SECOND CREATION: DOLLY AND THE AGE OF BIOLOGICAL
CONTROL 56 (Farrar, Straus & Giroux 2000).
16. Id. at 56.
17. Id. at 134.
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creating cloned people (reproductive cloning). 18 In therapeutic cloning, the
resulting embryo is not implanted into a woman for gestation as in
reproductive cloning.' 9 Rather, the embryo is allowed to divide in a
laboratory petri dish until it is made up of 100 to 150 cells, roughly the size
of a pin point.20 At this time, the five- to seven-day-old embryo, known as
a blastocyst, does not yet contain any distinctive body tissues.21 Blastocysts
created through nuclear transplantation share the same genetic material as
their parent.22 If a cloned blastocyst were implanted into a woman, a cloned
human being would result after gestation.23 However, the main focus of
scientific researchers conducting nuclear transplantation is not to create
people, but rather to create a source of embryonic "stem cells. 24
Stem cells are present in many tissues of the human body, and because
they are constantly self-generating, they serve to repair or replace damaged
cells within tissues. 25 In 1998, James Thomson from the University of
Wisconsin successfully isolated pluripotent stem cells from the inner cell
mass of human blastocysts.26 In doing this, Thomson discovered how to
maintain human embryonic stem cells indefinitely in a culture.27
Pluripotent cells such as embryonic stem cells have the potential to develop
into a variety of human tissues; they can give rise to almost any type of cell
in the human body.28
To generate embryonic stem cells, blastocysts created through nuclear
transplantation are tricked into thinking they are still at a stage where cell
division is supposed to occur without differentiation. 29 This deception is
carried out by placing the blastocyst in a petri dish overloaded with
molecular signals that foster proliferation of millions of identical,
18. Id. at 112-13.
19. Press Release, University of California San Francisco, UCSF Researchers Have
Explored Various Strategies Seeking Stem Cells (May 24, 2002) (available at
http://pub.ucsf.edu/newsservices/releases/200307222).
20. Id.
21. Id.
22. Id. Technically, the newly cloned blastocyst is not a perfect genetic copy because
some mitochondrial DNA that was present in the parent cell is not passed on to the clone.
23. Id.
24. WILMUT ET AL., supra note 15, at 233.
25. Id. at 233-34.
26. James A. Thomson et al., Embryonic Stem Cell Lines Derived from Human
Blastocysts, 282 SCIENCE 1145-47 (1998).
27. Id.
28. Stem cells of the blood and some other tissues are multipotent; they can give rise to
different forms of white and red blood cells, but they cannot give rise to other types of cells,
such as nerves or muscles. WILMUT ET AL., supra note 15, at 53.
29. LEE M. SILVER, REMAKING EDEN: HOW GENETIC ENGINEERING AND CLONING WILL
TRANSFORM THE AMERICAN FAMILY 150 (Avon 1998).
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undifferentiated cells. 30 By exposing this undifferentiated cell mass to
growth factors, researchers then force the embryonic cells down specific
pathways of differentiation into, for example, bone marrow or nerve cells.
31
Within a generation, scientists might discover which signals are needed to
convert embryonic cells into every kind of tissue that exists in the human
body.32
II. THE SOCIETAL VALUE OF SCIENTIFIC INQUIRY, AND THE BURDEN OF
PROOF ON THOSE WHO WOULD RESTRICT IT
Scientists have not always been given free rein to conduct research.
Until at least the Eighteenth Century, scientific research was often subject
to severe restrictions by ecclesiastical and civil authorities: "[fjear of
reprisal by the church, the state, or the mob was a major reason for cloaking
scientific activities in secrecy. '' 33 For the most part, scientific research in
America has rejected this repressive attitude, with the government
34supporting and funding science. The framers of the Constitution were
themselves products of Eighteenth Century Enlightenment thinking, which
venerated science.35  Freedom to pursue knowledge is "an enduring
American value, supported by scientists and non-scientists alike. 36  In
keeping with this American tradition of free scientific inquiry, Congress has
generally avoided banning any particular area of scientific research.
The Supreme Court recognized that historically, Americans have
30. Id.
31. Id.
32. Id. at 150-51.
33. HAROLD C. RELYEA, SILENCING SCIENCE: NATIONAL SECURITY CONTROLS AND
SCIENTIFIC COMMUNICATION 9-10 (Ablex Corp. 1994). Of course, in some parts of the
world, scientific (and non-scientific) expression is still repressed in a similar manner.
Lessons learned from these experiences inform a petition letter signed by forty Nobel
Laureates opposing restrictive cloning laws:
By declaring scientifically valuable biomedical research illegal, Senator
Brownback's legislation, if it becomes law, would have a chilling effect on all
scientific research in the United States. Such legal restrictions on scientific
investigation would also send a strong signal to the next generation of researchers
that unfettered and responsible scientific investigation is not welcome in the
United States.
Statement of Forty Nobel Laureates Regarding Cloning, The American Society for Cell
Biology (Apr. 10, 2002) (available at http://www.ascb.org/publicpolicy/Nobelletter.html).
34. See generally Steven Goldberg, The Constitutional Status of American Science, 1979
U. ILL. L.F. 1, 1 (arguing that the Constitution contains an implied science clause that
protects the publication of science-related information).
35. STEVEN GOLDBERG, CULTURE CLASH: LAW AND SCIENCE IN AMERICA 26 (New York
Univ. Press 1994).
36. NAT'L BIOETHICS ADVISORY COMM'N (NBAC) REPORT, CLONING HUMAN BEINGS 77
(June 1997) [hereinafter CLONING HUMAN BEINGS].
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6
Annals of Health Law, Vol. 14 [2005], Iss. 2, Art. 6
http://lawecommons.luc.edu/annals/vol14/iss2/6
Cloning for Biomedical Research
protected and encouraged scientific inquiry because of the great social
benefit in maintaining the sanctity of knowledge and the value of
intellectual freedom.37 Scientists have the responsibility of advancing
knowledge, and are thus granted a great deal of freedom "in the expectation
that knowledge beneficial to society will be yielded., 38 Because knowledge
is most likely to be advanced through empirical tests, 39 the scientific
researcher is expected to conduct experiments and press the frontier of our
understanding of the natural world. It is "contradictory to lay that
expectation upon [professional scientists and scholars] and then to prevent
its accomplishment by deterring its fulfillment through rules that punish its
exercise. '4° Thus, regulation of scientific inquiry is not to be taken lightly.
"[F]reedom of inquiry is a value of the very deepest importance which,
without most compelling reasons to the contrary, should not be abridged,', 1
and suppression of scientific inquiry is to be imposed only when vitally
important societal interests would be negatively impacted.
Many commentators have argued that restrictions on scientific research
are an unconstitutional infringement upon a fundamental right to free
scientific inquiry derived from the First Amendment.42 These arguments
probably go too far in protecting scientific research itself, as opposed to
37. Branzburg v. Hayes, 408 U.S. 665, 705 (1972). Similarly, the Supreme Court stated
in Meyer v. Nebraska that the right to liberty guaranteed by the Fourteenth Amendment
encompassed freedom to "acquire useful knowledge... and generally to enjoy those
privileges long recognized at common law as essential to the orderly pursuit of happiness by
free men." 262 U.S. 390, 399 (1923).
38. JOHN T. EDSALL, SCIENTIFIC FREEDOM AND RESPONSIBILITY 5 (Am. Ass'n for the
Advancement of Science 1975).
39. Carl Cohen, When May Research Be Stopped?, in THE RECOMBINANT DNA DEBATE
321-22 (David A. Jackson & Stephen P. Stich eds., Prentice-Hall 1979).
40. William Van Alstyne, The Specific Theory of Academic Freedom and General Issue
of Civil Liberty, in THE CONCEPT OF ACADEMIC FREEDOM 77-78 (E. Pincoffs ed., Univ. of
Tex. Press 1975). See also John T. Edsall, Scientific Freedom and Responsibility, Report of
the AAAS Committee on Scientific Freedom and Responsibility, 188 SCIENCE 687, 687-88
(May 16, 1975) ("Scientific freedom, like academic freedom, is an acquired right, generally
accepted by society as necessary for the advancement of knowledge from which society may
benefit.").
41. Alvin Zander, The Discussion of Recombinant DNA at the University of Michigan,
in THE RECOMBINANT DNA DEBATE, supra note 39, at 12-13.
42. See, e.g., Elizabeth Price Foley, The Constitutional Implications of Human Cloning,
42 ARIz. L. REv. 647, 677-87 (2000) (arguing that banning human cloning would encroach
on scientists' First Amendment "right of scientific inquiry"); Mathew B. Hsu, Banning
Human Cloning: An Acceptable Limit on Scientific Inquiry or an Unconstitutional
Restriction of Symbolic Speech?, 87 GEO. L.J. 2399, 2412-14 (1999) (arguing same);
Richard Delgado & David R. Millen, God, Galileo and Government: Toward Constitutional
Protection for Scientific Inquiry, 53 WASH. L. REv. 349 (1978) (arguing that scientific
inquiry is protected expression).
2005]
7
Gusman: An Appropriate Legislative Response to Cloning for Biomedical Res
Published by LAW eCommons, 2005
Annals of Health Law
protecting science-related publications.43  Scientists do not have the
unqualified freedom to pursue whatever inquiries they choose; research
undertakings may be constitutionally restricted whenever the government
has a rational basis for doing so. 44 The right of free inquiry must sometimes
yield to conflicting rights or to the demands of conflicting moral
principles.45 Still, our society's commitment to the freedom of inquiry is
such that, as a matter of policy rather than constitutional right, the burden of
proof should rest upon those who would prohibit an area of research.
Most decisions about whether to proceed with a type of research are
appropriately made by applying the utilitarian criterion of "the greatest
good for the greatest number," in which the soundness of a policy is
measured by comparing expected benefits to expected harms. 46 A
reasonable formulation might be that research or its by-product should only
be prohibited when it causes harm so great as to clearly outweigh the
reasonably anticipated benefits.47 Those who would ban therapeutic
cloning because they believe it is unethical to destroy embryos must show
not only that the harms outweigh expected benefits, but also that the harms
so greatly outweigh potential benefits so as to enforce this moral view
through criminal sanctions.48 By this reasoning, if the benefits equaled
harms, our society's commitment to scientific research would demand that
43. Regulation of scientific experiments to protect public health and safety or for other
valid reasons is constitutional. After all, the First Amendment protects speech, not action.
See GOLDBERG, supra note 35, at 86 ("biologists have no First Amendment right to perform
experiments in their basement when those experiments endanger the safety of the neighbors
or the environment. Properly drawn statutes, such as those relating to the use of plutonium,
can and do limit scientific experimentation to protect public safety."). Thus, prohibiting
therapeutic cloning is not a constitutional violation (provided there is a rational reason for
the legislature to object to the research), but rather, as this Note will suggest, merely unwise
policy.
44. Cohen, supra note 39, at 303. Even if scientific inquiry were determined to be a
fundamental constitutional right, the government could regulate to protect against
compelling harms. If the government can show that restrictions on cloning and cloning
technology are sufficiently important to the general well-being of individuals or society,
such restrictions would still be upheld as constitutional state action. See John A. Robertson,
The Scientist's Right to Research: A Constitutional Analysis, 51 S. CAL. L. REv. 1203, 1278
(1977); See also CLONING HUMAN BEINGS, supra note 36, at 77.
45. Stephen P. Stich, The Recombinant DNA Debate: Some Philosophical
Considerations, in THE RECOMBINANT DNA DEBATE, supra note 39, at 186.
46. See generally JOHN STUART MILL, UTILITARIANISM (George Sher ed., 2d ed. 2001).
We multiply the gravity of expected harms by the probability that they will occur, and weigh
it, as on a balance scale, against the product of reasonably anticipated benefits multiplied by
the likelihood of realizing those benefits (which may be referred to as expected utility).
Utilitarianism demands that we adopt the policy with the highest expected utility. See, e.g.,
Stich, supra note 45, at 194-95; Cohen, supra note 39, at 318.
47. Cohen, supra note 39, at 303.
48. See discussion infra Part VI.
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cloning research be allowed to continue. However, as the next section will
demonstrate, the scales are not balanced; anticipated benefits of therapeutic
cloning far outweigh its harms. It is critical to understand the potential
benefits of therapeutic cloning when combined with embryonic stem cell
research. The awesome potential of this line of applied science argues
strongly in favor of allowing cloning research to proceed.
Some commentators believe that because the destruction of human
embryos implicates our deeply felt moral intuitions, the deontological
theory, which focuses on the duty of right action instead of just
consequences, is an appropriate framework for making decisions about
therapeutic cloning.49 A deontological approach, however, would short-
circuit the discussion because therapeutic cloning cannot occur without the
destruction of embryos, a practice considered immoral by a significant
minority of Americans. 50  The advantage of this Note's utilitarian
framework is that it invites a broader discourse about the best possible
legislative policy on therapeutic cloning by requiring exploration and
balancing of both harms and benefits. 51
III. BENEFITS OF THERAPEUTIC CLONING
A. Why Stem Cells Should Continue to Be Developed from Embryos
A major argument against therapeutic cloning is that other alternatives
exist for creating stem cells, and we need not resort to nuclear
transplantation. Senator Brownback (R-Kan.) has voiced this argument:
"recent scientific advances indicate that there are fruitful and morally
unproblematic alternatives to [therapeutic cloning]. There is no need for
this technology to ever be used with humans. 52 It is true that "adult" stem
cells 53 can be obtained from the following sources in humans: tissues such
49. See, e.g., Makdisi, supra note 4, at 465-66.
50. At the very least, the debate within the deontological framework would have to
focus on whether the research process itself is immoral, a question that opens a veritable
Pandora's box, contemplating the relative moral status of the human embryo.
51. It is concededly quite difficult to quantify the harms and benefits likely to result
from therapeutic cloning. Harms are difficult to quantify because there is no ready formula
for how society should weigh the destruction of embryos. Benefits of therapeutic cloning
are perhaps even more difficult to quantify, because both their likelihood and the substance
of any future health benefits are to some extent speculative.
52 Sen. Sam Brownback, Bioethics: Human Cloning, at http://brownback.senate.gov/
LICloningText.htm (last visited Aug. 20, 2004).
53. A more accurate term for "adult stem cells" might be multipotent adult progenitor
cells. ANN A. KJESSLING & SCOTT C. ANDERSON, HUMAN EMBRYONIC STEM CELLS, AN
INTRODUCTION TO THE SCIENCE AND THERAPEUTIC POTENTIAt 142 (Jones and Bartlett
Publishers 2003) [hereinafter HUMAN EMBRYONIC STEM CELLS].
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as bone marrow, skin, or blood;54 umbilical cord blood and placentas; and
fetal tissues from aborted fetuses.55 Stem cells derived from human
embryos, however, have particularly desirable characteristics. Ian Wilmut,
one of the scientists who cloned Dolly the -Sheep, said, "[flor human
cloning at the cellular level to achieve its medical promise, it will become
necessary to do research on very early embryos, created specifically for this
purpose.
'56
Adult stem cells are generally thought to be less than ideal for research
since they have already begun forming specific cells and are less elastic. 7
Furthermore, they have not been isolated for all cell and tissue types, are
present only in minute quantities, are difficult to isolate and purify, 58 and
may lose their potency over time because they do not always grow well in
laboratory culture dishes.5 9  Embryonic stem cells, by contrast, can
proliferate indefinitely,60 and their chromosomal composition remains
stable throughout many cell cycles. 6' Embryonic stem cells work best
because they produce large quantities of undifferentiated cells and are
therefore pluripotent; that is, they have the potential to develop into any
kind of cell in the human body except for the cells needed to develop a
fetus.62  In contrast, adult stem cells have restricted developmental
potential.63 Thus far, only pluripotent stem cells have been isolated from
adult tissue; that is, cells capable of giving rise to some, but not all, cell
types.64
For example, adult nerve cells have been transplanted in numerous
54. When stem cell lines are created from adult tissues, the cells' nuclei must be
reprogrammed so that they become pluripotent. Id.
55. Because a fetus grows rapidly during the last six months of gestation, all of a fetus's
tissues and organs, including the brain, contain stem cells. Id.
56. THE CLONING SOURCEBOOK 128 (Arlene Klotzko ed., Oxford Univ. Press 2001).
57. Nat'l. Inst. of Health, NIH Backgrounder on Stem Cells [hereinafter NIH Stem Cell
Backgrounder], at www.nih.gov/news/backgrounders/stemcellbackgrounder.htm (last visited
Aug. 12, 2004).
58. Id.
59. This is a significant drawback, because any effective cell or tissue replacement
would require that transferred cells survive and continue to function normally for the lifetime
of the patient. Ian Wilmut, Human Cells from Cloned Embryos in Research and Therapy, 5
CLONING AND STEM CELLS 163, 164 (2003).
60. See generally M.J. Evans & M.H. Kaufman, Establishment in Culture of
Pluripotential Cells from Mouse Embryos, 292 NATURE 154 (1981).
61. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 145.
62. NIH Stem Cell Backgrounder, supra note 57.
63. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 145.
64. NIH Stem Cell Backgrounder, supra note 57. "Adult stem cells have not been found
for all types of tissue, but discoveries in this area of research are increasing. For example,
until recently it was thought that stem cells were not present in the adult nervous system, but
in recent years such stem cells have been found in the brain." Id.
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studies, but they have not formed functional connections with the host's
brain.65 Embryonic stem cells, by contrast, can be induced to differentiate
into mature neurons, nerves remarkably similar to those in the human body
and capable of transmitting electrical and chemical signals.66 The journal
Nature published a study in which neuronal stem cells derived from
embryos were successfully implanted in rats. This study illustrates the
principle that embryonic stem cells can integrate into a host and repair
damaged nerve cells without causing tumors.6 7 This breakthrough holds
great promise for the treatment of neurologic conditions such as
Parkinson's disease and spinal cord injury by creating healthy tissue for
replacement. 68
Recent studies indicate, however, that some adult stem cells may actually
be able to contribute to tissues other than their tissue of origin,69 and some
researchers believe adult stem cells are actually preferable to embryonic
stem cells because they are less likely to become cancerous. Additionally,
adult stem cell differentiation is easier to manage than embryonic stem cell
differentiation.70 Certainly, further study of adult stem cells is needed.71
Time will tell if pluripotent adult stem cells capable of contributing to a
wide variety of tissues can be developed, or if they are perhaps superior to
embryonic stem cells for therapeutic purposes. In the meantime, the
scientific community need not decide which type of stem cell is superior;
rather, research with both types should proceed simultaneously.
72
65. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 160.
66. Id.
67. See Jong-Hoon Kim et al., Dopamine Neurons Derived from Embryonic Stem Cells
Function in an Animal Model of Parkinson's Disease, 418 NATURE 50, 50-56 (2002); see
also HUMAN EMBRYONIC STEM CELLS, supra note 53, at 160-63 (discussing the Kim
experiment).
68. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 163.
69. See, e.g., C.M. Verfaillie et al., Unexpected Potential of Adult Stem Cells, 996
ANNALS N.Y. ACAD. Sci. 231 (2003); Daniel Q. Haney, Marrow Cells Surprisingly
Versatile, Study Finds, THE MIAMI HERALD, May 4, 2001, at A20.
70. Hearing on Stem Cell Research Before the Subcommittee on Labor, Health and
Human Services, and Education Appropriations Committee, 107th Cong. (July 18, 2001)
(testimony of Richard Doerflinger on behalf of the Committee for Pro-Life Activities United
States Conference of Catholic Bishops), available at 2001 WL 878936 (F.D.H.C.).
71. Donald Kennedy, Stem Cells: Still Here, Still Waiting, 300 SCIENCE 865, 865 (2003).
72. According to molecular neurobiologist Charles F. Stevens, "[iut is absolutely vital to
continue research using embryonic neural stem cells. It may be that, for reasons we don't
yet understand, adult stem cells will never be useful in therapy and that we will always need
embryonic cells. Or, it may be the other way around. We just don't know." HUMAN
EMBRYONIC STEM CELLS, supra note 53, at 164; see also NIH Stem Cell Backgrounder,
supra note 57 ("Given the enormous promise of stem cells [sic] therapies for so many
devastating diseases, NIH believes that it is important to simultaneously pursue all lines of
research and search for the very best sources of these cells.").
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B. Why Stem Cells Should Continue to Be Developed From Cloned
Embryos
Having demonstrated the superiority of embryonic stem cells, a question
remains: must we resort to cloning in order to conduct embryonic stem cell
research? Opponents of therapeutic cloning point to other sources of
embryos for research, such as "surplus" embryos created at in vitro
fertilization clinics.73  Stem cell lines created from cloned embryos,
however, offer key advantages. Nuclear transplantation is the fastest and
most reliable way to reproduce genetically identical stem cells.74 More
importantly, stem cells derived from cloned embryos would be autologous,
meaning they would be derived from the same individual who will receive
the replacement therapy, which minimizes the likelihood of tissue
rejection.75 Cloned embryos also have an application beyond stem cells:
through experiments with embryonic cells for which they already know the
genetic composition, scientists can gain a better understanding of how
inherited predispositions lead to a variety of cancers and neurological
diseases.76
It is only through the use of cloned embryos that the awesome potential
of "regenerative" medicine may be unlocked. Embryonic stem cells created
through nuclear transplantation offer the possibility of a renewable source
of replacement cells, tissues, or even fully formed organs for transplantation
into humans to regenerate or replace damaged or diseased body parts.
77
Potential applications range from skin grafts for burn victims and bone
marrow stem transplants for leukemia patients to nerve stem cell transplants
for neurodegenerative diseases.78 A recent survey published in Science
predicted that therapies developed from stem cells will eventually be able to
cure 125 million people in the United States. 79 According to the National
Institutes of Health (NIH), "[t]here is almost no realm of medicine that
might not be touched by this innovation.,
80
Eventually, stem cell lines created from cloned embryos could alleviate
the current shortage of transplantable organs and eliminate tissue rejection
based on genetic incompatibility. 8' Transplantable tissues and organs could
73. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 144.
74. Id. at 153.
75. Id.
76. Statement of Forty Nobel Laureates Regarding Cloning, supra note 33.
77. HUMAN CLONING: SCIENCE, ETHICS, AND PUBLIC POLICY, supra note 1, at 156-57.
78. Id.
79. HUMAN EMBRYONIC STEM CELLS, supra note 53, at xiii.
80. NIH Stem Cell Backgrounder, supra note 57.
81. The newly created tissue would be cloned from a person's own cells. The tissue
made from cloned cells would be virtually genetically identical to the patient's tissue, or at
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be effective in curing or reversing many serious illnesses and injuries,
including Parkinson's disease, juvenile diabetes, Huntington's disease,
amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), multiple
sclerosis, and spinal cord injury.82 Additionally, gene therapy could
potentially cure genetic diseases by replacing "defective" genes whose
nucleotides are not in the proper sequence with intact ones.83 The genetic
deficiencies would be corrected in culture: the embryonic stem cells derived
from the patient through nuclear transplantation would then be reinfused
into the patient, correcting the gene defect.84 These genetically engineered
stem cells could eventually cure genetic diseases such as cystic fibrosis,
hemophilia, and some types of cancer.85
C. The Uncertainty ofAchieving Health Benefits through Cloning Research
Critics of "therapeutic" cloning argue that the term itself is too
optimistic; there is no guarantee that stem cells grown from cloned embryos
will ever be used in the treatment of patients, or yield any results
whatsoever. The President's Council on Bioethics emphasized that there
are questions about the likelihood that this research will deliver its promised
benefits.86 Even proponents of therapeutic cloning concede that its potential
benefits are somewhat hypothetical and will require long-term investment.87
The perceived uncertainty of eventual benefits, however, is exaggerated
in light of the successes that have already been achieved. Scientists have
created and implanted a cow kidney from stem cells that were produced by
nuclear transfer.88 After transplanting the kidney under the skin of the
least similar enough at the level of the cell surface to evade immune surveillance. NIH Stem
Cell Backgrounder, supra note 57.
82. The President's Council on Bioethics, supra note 6, at 117. On the topic of cloning
for biomedical research, the Council is split into a majority opinion and a minority opinion.
Id. at xxxv-xxxix. To reach its decision, the Council discussed the moral and public policy
implications of cloning, both reproductive and therapeutic. Id. After significant discussion,
the majority of the council recommended that there be a four-year moratorium on cloning for
biomedical research (therapeutic cloning). Id. By contrast, the minority opinion
recommended that cloning for biomedical research be allowed with regulation. Id.
83. Makdisi, supra note 4, at 467-68.
84. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 177.
85. Id. at 177-78. Therapeutic application of stem cells might be particularly effective
against these genetic diseases because they have a well-known etiology and are thought to
involve a single genetic defect. Id.
86. The President's Council on Bioethics, supra note 6, at 117.
87. Carol A. Tauer, Responsibility and Regulation: Reproductive Technologies, Cloning,
and Embryo Research, in CLONING AND THE FuTURE OF HUMAN EMBRYO RESEARCH 146
(Paul Lauritzen ed., Oxford Univ. Press 2001).
88. See R.P. Lanza et al., Generation of Histocompatible Tissues Using Nuclear
Transplantation, 20 NATURE BIOTECHNOLOGY 689-96 (July 2002).
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donor cow, researchers found that it performed some functions of a normal
kidney, including the excretion of urine.89 Most importantly, there was no
indication of tissue rejection by the donor-host.90 In 2002, researchers
reported the first successful application of nuclear transplantation to
produce stem cells that could be used for cell-based treatment in
mammals.91  The clinical potential of stem cells in general has been
demonstrated in the treatment of diabetes and advanced kidney cancer,
among other diseases.92 In 2001, Israeli researchers were able to create
insulin-secreting structures similar to pancreatic islet cells from human
embryonic stem cells.93 This discovery indicates that it may be possible in
the future to derive cell replacement therapies from stem cells for the
treatment of diabetes.94 Currently, research has yet to solve some of the
problems associated with insulin-producing structures derived from stem
cells, 95 but this simply points to the need for more research in this area.
Scientists in cloning laboratories are continually learning about cellular
function and gene expression, which may also have applications in other
areas of medicine. A better understanding of cell development will allow
us to understand and perhaps correct the genetic errors that cause serious
medical conditions.96 Notwithstanding the fact that the National Bioethics
Advisory Commission (NBAC) has remarked on the "important scientific
and biomedical advances"' 97 cloning research has already provided.
89. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 175.
90. Id. Of course, the fact that the bioengineered tissue in the Lanza study was not
rejected, supra note 87, demonstrates that rejection will not necessarily occur when the
nuclear transfer approach is used, but does not prove that rejection will never occur. See
Hugh Auchincloss & Joseph V. Bonventre, Transplanting Cloned Cells into Therapeutic
Promise, 20 NATURE BIOTECHNOLOGY 665-66 (2002).
91. W.M. Rideout et al., Correction of a Genetic Defect by Nuclear Transplantation and
Combined Cell and Gene Therapy, 109 CELL 17-27 (2002).
92. NIH Stem Cell Backgrounder, supra note 57.
93. Suheir Assady et al., Insulin Production by Human Embryonic Stem Cells, 50
DIABETES 1691, 1691-97 (2001).
94. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 172.
95. The procedure is at this time highly inefficient, yielding insulin-producing cells only
once in every hundred attempts. Unfortunately, there appears to be an inverse relationship
between the ability to proliferate and the ability to differentiate. The cells that grow well do
not produce therapeutic levels of insulin, while those that produce insulin do not grow at a
sufficiently rapid rate. HUMAN EMBRYONIC STEM CELLS, supra note 53, at 171-72; see
Bemat Soria et al., Insulin-Secreting Cells Derived from Embryonic Stem Cells Normalize
Glycemia in Streptozotocin-Induced Diabetic Mice, 49 DIABETES 157, 157-62 (2000).
96. NIH Stem Cell Backgrounder, supra note 57.
97. Report of the Nat'l Bioethics Advisory Comm'n, CLONING HUMAN BEINGS. NBAC
was established by President Clinton in October of 1995 to advise and make
recommendations regarding bioethical issues and to "identify broad principles to govern the
ethical conduct of research." Exec. Order No. 12,975, 60 Fed. Reg. 52,063 (Oct. 3, 1995).
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Arguably, the chief reason there is a lack of convincing data on the use of
embryonic stem cells to treat serious diseases is the current federal funding
moratorium for these lines of inquiry. As a result, the development of
embryonic stem cells has been limited to relatively few companies and
laboratories in the private sector. Therefore, because for-profit entities
understandably want to capitalize on their own research advances, the
results of this research are not available to the scientific community at
large.98
Regardless of the level of success already achieved in the cloning labs,
uncertainty about future success alone does not justify a statutory ban on
experimentation. The eventual results of all research are to some extent
uncertain. The banning of scientific inquiry requires compelling reasons,
and it is difficult to weigh the risks against the benefits until the extent of
the potential benefits is better understood. Furthermore, it is likely that the
technical difficulties currently experienced in developing stem cell lines
from cloned embryos will be solved in the not-too-distant future.
The scientific community continually announces discoveries that turn
conventional theories on their head. For example, the fairly recent
breakthrough of nuclear reprogramming, in which scientists have directed
fully differentiated cells back to a totipotent state, is a good example. 99
What seemed impossible yesterday may become commonplace in the near
future. If therapeutic cloning is allowed to proceed, it is even possible that
a new method of extraction may develop, whereby stem cells could be
extracted without destroying the cloned embryos.' 00 Such a technique
would provide health benefits while at the same time assuaging critics who
object to nuclear transplantation because of embryo destruction. Surely
even those who stress that the potential of therapeutic cloning is speculative
should avoid cutting off an area of emerging technology that could lead to
revolutionary health benefits.10' Perhaps this is why Congress has not yet
98. J.D. Rowley et al., Harmful Moratorium on Stem Cell Research, 297 SCIENCE 1957
(2002).
99. Alan Colman, Turning Back the Development Clock, 20 NATURE BIOTEHNOLOGY
348 (2002).
100. Currently, the inner cell mass of blastocysts, the developmental precursors to
embryos, are used in isolating stem cell lines. Roughly five days post-fertilization, the
blastomere becomes a blastocyst, which in turn becomes an embryo around Day 14. In the
future, a technique may be developed allowing stem cells to be isolated directly from
blastomeres, the cells that result immediately from the cleavage of an activated egg: a
technique in which no embryo or blastocyst would be destroyed. HUMAN EMBRYONIC STEM
CELLS, supra note 53, at 151. As the blastomeres divide (or, more accurately, cleave), their
cell functions are thought to not yet be controlled by the genes of the newly created or
fertilized embryo, but rather by the genome of the oocyte (egg). Id. at 65-66.
101. ANDREA L. BONNICKSEN, CRAFTING A CLONING POLICY: FROM DOLLY TO STEM
CELLS 56 (Georgetown Univ. Press 2003).
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passed a statutory ban.
IV. ADDRESSING THE ETHICAL ARGUMENTS AGAINST THERAPEUTIC
CLONING
The potential benefits of cloning for biomedical research, and its
potential application in tissue replacement therapies, justify the harms
involved in the research. In other words, the opponents of therapeutic
cloning have not met their burden of showing the harms of therapeutic
cloning outweigh the sum of advantages likely to accrue from such
research. It is important to separate the issues of therapeutic and
reproductive cloning because they have differing rationales and present
distinct ethical dilemmas. The birth of a genetically identical person is the
primary objection to reproductive cloning, while the chief objection to
therapeutic cloning is that the embryos are created solely for the purposes of
research and then destroyed. 
102
The most fundamental argument against permitting therapeutic cloning is
that it involves the deliberate production, use, and ultimate destruction of
cloned human embryos. 13 Properly weighing harm to the embryo versus
the benefit to society necessarily requires some determination of the moral
status of the human embryo. The American public exhibits a wide range of
opinions on this issue. In fact, even reaching consensus on an approach to
analyzing the issue is difficult. One commentator has stated that to some
extent, the debate over the morality of embryo research is at an impasse,
asking, "[d]o those who defend embryo research have to show why it is
morally justifiable, or do those who oppose it have to show why it is
morally wrong?"'o4
While some believe that the preimplantation embryo is neither a human
individual nor the sort of entity that demands significant protection, others
hold that the preimplantation embryo is a human being, or may be a human
being, and hence embryo research is prima facie prohibited.'0 5 For the
latter group, the burden of proof is on the scientist, and any research must
have a moral justification that overrides the prima facie prohibition. 06 At
one extreme are those who say the embryo is equivalent to a human
being.1 7 Put another way, life is sacred from the moment that its biologic
102. The President's Council on Bioethics, supra note 6.
103. Id.
104. Tauer, supra note 87, at 145.
105. Id. at 151-52.
106. Id.
107. John T. Noonan, Jr., An Almost Absolute Value in History, in THE MORALITY OF
ABORTION: LEGAL AND HISTORICAL PERSPECTIVES 57 (John T. Noonan, Jr. ed., 1970).
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character is defined by receipt of its genetic material. 0 8  Therefore,
embryos should be given the rights, protections, and respect that we give to
all other human beings. This is the current position of the Catholic
Church. 109 At the other extreme are those who say that the embryo is no
different from any other clump of human cells and should not be treated in
any special way; life is sacred only after birth.
This Note adopts a middle view between the two extremes: human
embryos should be accorded respect because of their human potential. The
embryo is not actual human life, but a potential human life." ° As
reproductive ethicist John Robertson wrote:
The embryo deserves respect greater than that accorded to other human
tissue, because of its potential to become a person and the symbolic
meaning it carries for many people. Yet it should not be treated as a
person, because it has not yet developed the features of personhood [such
as neurological attributes] ... and may never realize its biologic
potential.",I
If the embryo were to eventually develop into a fetus and be born, it would
be endowed with a full panoply of rights that would trump application of a
pure utilitarian framework."12
Apart from the more general question of whether embryo research is
108. Id.
109. Tauer, supra note 87, at 145.
110. SILVER, supra note 29, at 48; see also Heather Johnson Kukla, Embryonic Stem Cell
Research: An Ethical Justification, 90 GEO. L.J. 503, 520 (2002) ("Under the symbolic view,
an embryo is not a holder of rights and interests because it is not yet a human person;
however, as a developing form of human life, it is a powerful symbol of human life."); Nat'l
Bioethics Advisory Comm'n, Ethical Issues in Human Stem Cell Research (1999), available
at http://www.georgetown.edu/research/nrcbl/nbac/pubs.html ("[A]lthough the human
embryo... deserve[s] respect as [a] form of human life, the scientific and clinical benefits of
stem cell research should not be foregone."); Davis v. Davis, 842 S.W.2d 588, 596 (Tenn.
1992) (the human embryo is entitled to respect greater than that owed to human tissues
because of if its "symbolic" value and its potential to develop into a human person, but the
respect owed is less than that owed to "persons" because it lacks the features of a developed
person and "may never reach its biological potential.").
111. SILVER, supra note 29, at 48. Harold Varmus, the director of NIH, commissioned
the Human Embryo Research Panel (HERP) in 1994 to assess the types of embryo research
that should and should not be acceptable for federal funding and to propose any warranted
guidelines for research beyond those already in place (research with in utero fetuses and fetal
tissue transplantation were already forbidden federal funding). HERP concluded that
embryo research was ethically acceptable under carefully defined conditions and
qualifications. In arriving at this conclusion, the panel determined that preimplantation
embryos do not have the moral status of a full human subject and thus do not require all the
protections due such a subject. Tauer, supra note 87, at 150.
112. Dan W. Brock, Cloning Human Beings: An Assessment of the Ethical Issues Pro
and Con, in CLONING AND THE FuTuRE OF HUMAN EMBRYO RESEARCH, supra note 87, at 95.
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permissible, is it permissible to bring human embryos into existence for
purposes of research? This is a unique ethical dilemma presented by
therapeutic cloning. Those who oppose therapeutic cloning for this reason
flip on its head a traditional argument against reproductive cloning, namely
that the cloned embryos should not result in a human being. 1 3 According
to this view, the research is impermissible because it creates "human life
that may not be intended to come to fruition."'1 14 Some oppose the creation
of embryos for research purposes, although they do not object to the use of
embryos that remain after infertility treatments." 5 The use of surplus
embryos in research is defended by the argument that they were initially
created for a procreative purpose for which they are no longer needed, and
hence may now be used for another worthwhile purpose. 16 It may be
argued that the ethical basis is found in:
[T]he nature of the original intention (where procreation is regarded as a
legitimate goal for In vitro fertilization (IVF), but research is not) or the
necessity to choose the "lesser evil" (assuming that the existence of
surplus embryos forces us to choose among undesirable options: discard,
indefinite frozen storage, or research use).
A related argument is that even if we allow research involving the
byproducts of assisted reproduction ("spare" embryos), we should not allow
the deliberate creation of embryos for research because doing so is not a
legitimate goal for meddling in the procreative process." 8 According to
this view, reproductive interventions are justified only insofar as they serve
the goals of responsible human reproduction: the "bringing forth of new life
in loving and nurturing relationship." ' 19 Fertilization not linked with
reproduction is problematic because it stands outside of the goods and
values that medically-assisted reproduction appropriately serves. 20 The
risks to be weighed, therefore, involve the traditional balancing of moral
anxieties over the treatment of embryos against the social importance of the
research, as well as society's interest in the integrity of sexuality,
reproduction, and parenthood. 121
113. Tauer, supra note 87, at 146.
114. Id.
115. Id. at 152
116. Id.
117. Id.
118. Maura A. Ryan, Creating Embryos for Research: On Weighing Symbolic Costs, in
CLONING AND THE FUTURE OF HUMAN EMBRYO RESEARCH, supra note 87, at 51.
119. Id.
120. Id.
121. Ryan, supra note 118, at 66; see also Carol A. Tauer, Bringing Embryos into
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However, when contrasting the discretion IVF clinics have in embryo
research with currently proposed legislative bans of therapeutic cloning, the
preceding arguments against embryo research break down. In the United
States, there is no comprehensive regulatory scheme for IVF or embryo
research. 22  Today, embryo research is funded by private investment
proceeds in the private sector. In addition, the more than four hundred
fertility clinics throughout the country conduct extensive experimentation
on reproductive technologies, usually involving human embryos, with little
or no federal oversight. 123 The lack of federal funding has also led to a lack
of regulation, resulting in private research not being regulated at the federal
level. 24 Guidelines and ethical considerations have been developed by the
fertility industry, but compliance is voluntary.
125
It is inconsistent to allow IVF clinics to destroy embryos in pursuing
assisted reproduction while at the same time banning research that does the
same. Both procedures involve discarding embryos. If preimplantation
embryos deserve protection, it should not matter that therapeutic cloning
destroys them in research while IVF clinics destroy them in attempting
reproduction. Assisted reproductive technologies are not only legal, but are
barely regulated at all. Except for a clinical reporting requirement, there is
no regulation at the federal level, and assisted reproductive technologies are
barely regulated by the states. Given the disparity in our legislative
response to the two activities, it appears that much of the opposition to
therapeutic cloning may be based on the fear of potential human clones.
Currently, neither cloning nor embryo research may legally be funded by
federal agencies such as the National Institutes of Health (NIH), the source
of most federal research grants. 26 However, there are currently no federal
Existence for Research Purposes, in CONTINGENT FUTURE PERSONS: ON THE ETHICS OF
DECIDING WHO WILL LIVE, OR NOT, IN THE FUTURE 171-89 (Nick Fotion & Jan C. Heller
eds., Kluwer Academic Pub. 1997). Professor Leon Kass, chairman of the President's
Council on Bioethics, argues that IVF and other assisted reproductive technologies that place
the "origin of human life literally in human hands" have led to "the continuing erosion of
respect for the mystery of sexuality and human renewal." LEON R. KASS & JAMES Q.
WILSON, THE ETHICS OF HUMAN CLONING 80 (AEI Press 1998). Kass argues that weakening
human respect for the profundity of sexual union would lead to the replacement of
procreation with manufacturing. Id. at 80-81.
122. Though with respect to embryo research, several states do have restrictive laws.
123. THE CLONING SOURCEBOOK, supra note 56, at 127; Tauer, supra note 87, at 148-49.
The only federal oversight is a congressional reporting requirement for clinics. See Fertility
Clinic Success Rate and Certification Act of 1992, Pub. L. No. 102-493, 106 Stat. 3146
(1992).
124. Tauer, supra note 87, at 148-49.
125. THE CLONING SOURCEBOOK, supra note 56, at 127. See Ethics Comm. of the Am.
Fertility Soc'y, Ethical Considerations of Assisted Reproductive Technologies, 62 FERTILITY
& STERILITY SUPP. 5 (1994).
126. Tauer, supra note 87, at 148-49.
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prohibitions of either type of research when carried out in the private
sector.127  Researchers in the private sector are free to clone embryos
through nuclear transplantation, except in the handful of states where this
research is prohibited by statute. 28  Technically, there is no statute or
directive that specifically prohibits federal funding of the cloning technique
itself. However, since 1995, federal policy has prohibited funds for
research in which human embryos are destroyed, 129 a limitation which
almost all commentators agree would extend to embryos generated through
nuclear transplantation. 130  Because cloning would be used to create
embryos for further research, the limitation on such research serves as a de
facto limitation on the funding of therapeutic cloning.
This limitation on funding is consistent with Congress's common
practice of refusing to fund procedures or experiments that are morally
controversial;' however, there is no similar tradition of criminalizing a
type of scientific research simply because it is morally controversial. In
1979, within a year of the birth of the first IVF baby, the now-defunct
Ethical Advisory Board of the Department of Health, Education and
Welfare (HEW) (now the Department of Health & Human Services (HHS))
concluded that IVF research was ethical. 132 Nevertheless, HEW rejected
federal funding for IVF research because the moral issues surrounding IVF
made it too politically controversial.
133
The debate over fetal tissue transplantation (research on tissue from
aborted fetuses) has, like the debates regarding IVF research and stem cell
research, properly focused on whether it should receive public funding, not
whether conducting this research should be criminalized. Contrary to the
127. Id.
128. See supra note 3.
129. The Omnibus Consolidated and Emergency Supplemental Appropriations Act
prohibits federal funding to create human embryos for research purposes or for "research in
which a human embryo or embryos are destroyed, discarded, or knowingly subjected to" a
greater than minimal risk of injury or death. Pub. L. No. 105-277, § 5 11(a), 112 Stat. 2681-
386 (1998).
130. THE CLONING SOURCEBOOK, supra note 56, at 128. Congress has prohibited NIH
from using federal funds to finance any research in which human embryos are harmed or
destroyed outside the womb. This was done through the "Dickey-Wicker amendment" to the
appropriations bills funding the National Institutes of Health, passed every year since 1995.
Id.
131. Cf Harris v. McRae, 448 U.S. 297, 314, 319 (1980) (stating that Congress may
deny federal funding to abortions in passing moral judgment intended to influence citizens'
behavior); Rust v. Sullivan, 500 U.S. 173 (1991) (recipients of federal family planning funds
could be prohibited from engaging in abortion counseling).
132. Keith Alan Byers, Infertility and In Vitro Fertilization: A Growing Need for
Consumer-Oriented Regulation of the In Vitro Fertilization Industry, 18 J. LEGAL MED. 265,
291 (1997).
133. Id.
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recommendations of an NIH Advisory Committee, on March 22, 1988, the
Assistant Secretary for HHS imposed a temporary moratorium on federal
funding of research involving tissue from aborted fetuses. 134 On his second
day of office in 1993, President Clinton issued an executive order lifting
this ban on federal funding. 35 Current federal law and regulations allow
federal funding of experimentation on human fetal tissue pending approval
by a federally-sanctioned Institutional Review Board.
36
In the United Kingdom, nationally funded therapeutic cloning exists
because the country not only allows, but also funds, the creation of embryos
for research purposes. 137 In the United States, by contrast, federal funding
for this type of research is extremely unlikely, given the political opposition
to public funding for any type of embryo research. The American political
debate is limited by the fact that research involving the deliberate creation
of embryos not destined to be implanted has never received federal
funding. 38  One commentator has remarked that in the United States,
therefore, "concerns about creating and destroying human embryos have
superimposed the unresolved politics of embryo research onto the politics
of cloning."' 139 This situation does not appear to be amenable to change any
time in the near future. Given the absence of a consensus on the morality of
embryo research, prohibitions of public funding are reasonable because, as
the Human Embryo Research Panel (HERP) stated in its report on embryo
research, public policy is the "accommodation of diverse interests."'
' 40
A. The "Slippery Slope" to Human Reproductive Cloning
Another chief argument against permitting cloning research is that it
could pave the way for the eventual cloning of a human child.' 41 This is the
134. Office of Science Policy and Planning, Report to Congress, Theraputic Human
Fetal Tissue Transplantation Research Activities Funded by the National Institutes of Health
in FY 1998 (July 1999), at http://ospp.od.nih.gov/policy/fetal.asp (last visited Aug. 12,
2004).
135. Memorandum for the Secretary of HHS, Federal Funding of Fetal Tissue
Transplantation Research, 58 Fed. Reg. 7457 (Jan. 22, 1993).
136. See 42 U.S.C. § 289 (2003); 45 C.F.R. § 46.101 (2003).
137. THE CLONING SOURCEBOOK, supra note 56, at 128-29.
138. At the state level, Missouri passed a law providing that "[n]o state funds shall be
used for research with respect to the cloning of a human person." MO. ANN. STAT. § 1.217
(West 2002).
139. THE CLONING SOURCEBOOK, supra note 56, at 128-29.
140. Brian Stiltner, Morality, Religion, and Public Bioethics: Shifting the Paradigm for
the Public Discussion of Embryo Research and Human Cloning, in CLONING AND THE
FuTuRE OF HUMAN EMBRYO RESEARCH, supra note 87, at 182.
141. See President George W. Bush, Remarks by the President on Human Cloning
Legislation (Apr. 10, 2002) (available at http://www.whitehouse.gov/news/releases/2002/0 4 /
20020410-4.html) (last visited Aug. 10, 2004).
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classic "slippery slope" argument, the notion that it will be more difficult to
prevent the cloning of human beings once embryos are already being
cloned. The most effective way to prevent cloning of humans, the
argument goes, is to stop the process at the initial act of cloning. President
Bush has said, "we must prevent human cloning by stopping it before it
starts., 142  Rep. David Weldon, one of the proponents of the Human
Cloning Prohibition Act of 2003, said, "[t]hose who perform experimental
research cloning will only make reproductive cloning easier, and increase
the likelihood that even more rogue scientists will produce cloned
babies.,,
143
This argument is flawed, however. It seems unlikely that policymakers
would use the fact that therapeutic cloning is permitted to justify the
cloning of human beings, even though embryos produced for research are
no different from cloned embryos that could be used to produce cloned
children. 144 Scientific inquiry should not be blocked "simply upon the
presentation by critics of a parade of imagined horribles" if these are in fact
unlikely to occur.
145
Here, the allegedly harmful future event is the eventual cloning of human
beings. But would the existence of cloned embryos actually bring about the
cloning of a human being? Certainly, the existence of a cloned embryo is a
prerequisite for creating a cloned human being. But assuming a ban on
reproductive cloning only, it is difficult to believe that someone who is
determined to illegally clone a person would be any more deterred from the
practice if it were also illegal to make the clone in the first place.
The argument fails to address why it would not be a sufficient deterrent
to simply prohibit the implantation of a cloned embryo into a woman's
uterus, as the United Kingdom has done. Moreover, when the increased
probability of cloned human beings is proffered as a justification for
banning therapeutic cloning, it is important to recognize that the
probabilities involved are not whether humans will be cloned (which can be
handled through a ban on reproductive cloning), but whether allowing
therapeutic cloning adds to this probability. Ultimately, there is no real
evidence to back up the claim that allowing the cloning of embryos will
necessarily facilitate the birth of cloned humans. Rather, this claim seems
to be an overreaction motivated by the fear of reproductive cloning.
There is reason to think that the "slippery slope" position is too alarmist
142. Id.
143. Statement of Rep. Dave Weldon (Jan. 8, 2003) (available at http://www.house.gov/
stupak/press2003-2004/010803cloningban.html) (last visited May 19, 2005).
144. Tauer, supra note 87, at 146.
145. Cohen, supra note 39, at 213.
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because even without a ban on therapeutic cloning, there are existing
hurdles to the creation of cloned human beings. First, cloned embryos
would not be lying around science labs all over the country. Nuclear
transplantation is an extremely costly process, funded exclusively by
private companies, with no prospect of federal funding in the near future.
The profit motive alone provides sufficient incentive for those who create
cloned embryos to keep them from falling into third parties' hands.
146
Even if some embryos were stolen or illegally sold, a limited number of
labs and organizations in the United States have the capacity to clone.
147
Despite the absence of a federal ban, the American Society for
Reproductive Medicine, the Biotechnology Industry Organization, and the
Federation of American Societies of Experimental Biology have already
agreed in principle to a voluntary moratorium on human cloning. These
three groups represent virtually all scientists who currently have the
capacity to clone. 148 Further, in the absence of any other federal regulation,
the United States Food and Drug Administration (FDA) has asserted its
authority to ensure that experimentation with nuclear transplantation to
create a human child will not begin until the procedure is deemed safe
enough. 149 In short, even if the cloning of embryos is permitted for limited
purposes, it does not follow that banning reproductive cloning makes
human cloning inevitable, or even much more likely.
V. INVOKING THE CRIMINAL SANCTION
To borrow from the classic work of Herbert L. Packer, criminalizing
therapeutic cloning would violate several fundamental principles that serve
146. The cloned embryos are not likely to be sold, either, because federal law already
prohibits the profit in interstate commerce from the sale of human embryos.
147. HUMAN CLONING: SCIENCE, ETHICS, AND PUBLIC POLICY, supra note 1, at 123.
148. Id. Severe complications are often associated with mammalian reproductive
cloning. Cloned embryos often exhibit developmental abnormalities. Moreover, only a tiny
proportion (less than one percent) of cloned mammals make it to birth, and many of the
offspring that are born suffer from various birth defects. A. Hadjantonakis & V.E.
Papaioannou, Can Mammalian Cloning Combined With Embryonic Stem Cell Technologies
Be Used to Treat Human Diseases?, 3 GENOME BIOLOGY 1023.1, 1023.1 (2002). These
problems create a valid argument as to why reproductive cloning should be banned;
however, they do not provide adequate justification for proscription of therapeutic cloning.
The flaws apparent in the reproductive cloning process do not impede the use of nuclear
transplantation for therapeutic applications. Rudolf Jaenisch et al., Nuclear Cloning, Stem
Cells, and Genomic Reprogramming, 4 CLONING & STEM CELLS 389, 394 (2002). In fact,
the danger and inefficiency of mammalian cloning at this point is evidence that even if
cloning research is allowed to proceed in the private sector, scientists are not likely to
attempt to clone human beings, at least for the foreseeable future.
149. Letter from Sharon Smith Holston, Dep. Comm'r for External Affairs, Food and
Drug Admin., to Sen. Edward Kennedy (Feb. 10, 1998) (inserted in 144 Cong. Rec. S562
(daily ed., Feb. 10, 1998)).
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to limit the usefulness of the criminal law.' 50 First, conduct that is remote
from the feared harm should not be criminalized. Opponents of therapeutic
cloning raise the specter of reproductive cloning. If reproductive cloning is
the harm feared, then prohibit it. Do not throw the baby out with the bath
water by prohibiting therapeutic cloning, which is one step removed from
the creation of identical humans, and thereby lose all the potential benefits
of the research. 151 Instead of prohibiting the process of cloning itself, a less
restrictive option is for the legislature to target the act of implanting a
cloned embryo with the intent to create a human being. Great Britain's
Human Reproductive Cloning Act of 2001 criminalized reproductive
cloning by targeting the placement "in a woman of a human embryo which
has been created otherwise than by fertilisation.' 52 This way, reproductive
cloning is still prohibited, but cloning for biomedical research can continue.
Next, only conduct that is viewed as immoral, without significant social
dissent, should be criminalized.153 This principle is designed to avoid the
risks of imposition upon minorities and the specter of unenforceability 54
There are many people who do not view therapeutic cloning as immoral,
including most of the scientific community. 55
Criminalization must also serve the goal of deterring crime.156 Conduct
to which people feel deeply committed should not be criminalized because
they will not be adequately deterred. 57 The deterrent value of a criminal
ban on scientific inquiry is questionable. Historically, scientists committed
to pursuing knowledge and truth have not been deterred from their research
even under threat of prosecution. Moreover, laws should not be enacted
that cannot be enforced. There are serious monitoring and enforcement
problems with a criminal proscription of cloning for research because
cloning only occurs in laboratories, and enforcement of a therapeutic
150. See generally HERBERT L. PACKER, THE LIMITS OF THE CRIMINAL SANCTION (1968)
(questioning what the criminal sanction is good for).
151. See Roger B. Dworkin, Biocatastrophe and the Law: Legal Aspects of Recombinant
DNA Research, in THE RECOMBINANT DNA DEBATE, supra note 39, at 227 (arguing against
the criminal prohibition of recombinant DNA research).
152. Human Reproductive Cloning Act 2001, c. 23 (Eng.), available at
http://ww.legislation.hmso.gov.uk/acts/acts2001/20010023.htm (last visited Aug. 20, 2004).
153. PACKER, supra note 150, at 262.
154. Dworkin, supra note 151, at 227.
155. See, e.g., Four of Five Oppose Human Cloning: U.S. Funding of Stem Cell
Research Has More Acceptance, a Survey Reports, GRAND RAPIDS PRESS, Apr. 14, 2002, at
A6 (explaining that while most of the public opposes cloning, two-thirds of Americans do
not oppose federal funding of stem cell research) (available at 2002 WL 11909813).
156. Deterrence has been defined as "the inhibiting effect that punishment, either actual
or threatened, will have on the actions of those who are otherwise disposed to commit
crimes." PACKER, supra note 148, at 39.
157. Dworkin, supra note 151, at 227.
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cloning ban would require intrusions into private, often high-security,
locations.
158
Conduct should not be criminalized unless society seriously wants the
law enforced and violators imprisoned.' 59 It is not in society's best interest
to imprison its top scientific minds if they are attempting to ameliorate
human suffering. 160  Additionally, the enforcement of anti-cloning laws
diverts scarce police, prosecutorial, and judicial resources away from
serious crimes such as murder, robbery, and rape. Lastly, the criminal
sanction is already overused in our society, and the costs of this overuse are
enormous. 161
There are several reasons why therapeutic cloning is particularly
inappropriate for criminal prohibition. Because the nuclear transplantation
technique already exists and is used around the world, prohibiting it here
will serve only to deny Americans its benefits while failing to eliminate its
practice elsewhere. 62 In addition, because legislatures are ill-equipped to
obtain, understand, and react to current scientific information, modesty is
the wisest legislative policy when it comes to science. 163 Even assuming
the legislature has access to the most current scientific information, it is
impossible for the drafters of legislation to keep up with the pace of
technological change, particularly in the rapidly changing field of
reproductive technologies. LeRoy Walters has referred to this as the
"instant obsolescence" problem.164  The National Bioethics Advisory
Commission (NBAC) pointed out in its 1997 report that it is "notoriously
158. On the other hand, because the nuclear transplantation process is costly and
requires specialized equipment and knowledge, this type of research is occurring in very few
laboratories across the country, possibly indicating easier enforcement.
159. PACKER, supra note 150, at 262.
160. Dworkin, supra note 151, at 227.
161. Dworkin, supra note 151, at 226; see also Task Force on the Federalization of
Criminal Law, THE FEDERALIZATION OF CRIMINAL LAW 7 n.9 (Washington, DC: American
Bar Association, 1998) (noting that more than a quarter of federal criminal laws enacted
since the Civil War have been enacted since 1980); John C. Coffee, Jr., Paradigms Lost: The
Blurring of the Criminal and Civil Law Models-And What Can Be Done About It, 101
YALE L.J. 1875, 1877 (1992) ("[C]riminal law should not be overused.").
162. Dworkin, supra note 151, at 226. On the other hand, there does seem to be a
growing movement throughout Europe and other Western nations to ban both types of
cloning. Germany and Norway prohibit embryo research and cloning, both reproductive and
therapeutic. Even in the Netherlands, a country normally considered very liberal, the
Parliament adopted a law to ban the cloning of human embryos. The Council of Europe,
which includes not only the fifteen European Union member states but also more than forty
countries including Russia and Turkey, adopted a convention on biomedicine that prohibits
the creation of human embryos for research purposes.
163. Dworkin, supra note 151, at 228.
164. LeRoy Walters, Ethics and New Reproductive Technologies: An International
Review of Committee Statements, HASTINGS CENTER REP., June 1987, at 3, 9.
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difficult to draft legislation at any particular moment that can serve to both
exploit and govern the rapid and unpredictable advances of science., 165 If
the anti-cloning law is worded loosely, it may proscribe too much. On the
other hand, a law tailored to one specific technique, such as nuclear
transplantation, might not provide a framework for later innovations in
reproductive and genetic technologies. 
166
An ambiguous definition of cloning could shut down a significant
amount of otherwise uncontroversial research. For example, "anti-cloning
laws could prohibit or stifle tremendous opportunities that derive from the
application of cloning techniques to animal biotechnology" through
selective breeding. 167 The NBAC cautions that any regulatory or legislative
actions "should be carefully written so as not to interfere with other
important areas of scientific research," such as the cloning of human DNA
sequences or animals by nuclear transplantation. 168 To give one example of
the dangers of ambiguity, Britain's Human Fertilization and Embryology
Act of 1990 was intended to ban human reproductive cloning, but some
think the Act contains loopholes that actually permit human cloning.
169
Although the legislation prohibits the transplant of nuclei into embryos, it
may not explicitly forbid nuclear transplantation, which is the transfer of
nuclei into eggs. 170 Laws can always be amended, but "revisiting a law is
awkward and not always successful, which leaves legitimate activities in a
state of legal limbo.'
171
Legislatures often struggle to understand innovative issues requiring
profound scientific expertise. Legislatures must often hastily responded to
public outcry. In drafting legislation in response to such issues, the
resulting law may be incomplete and vague. Such statutes, therefore, may
have the effect of inhibiting rather than encouraging the study of therapeutic
cloning. For example, if a Virginia researcher is studying therapeutic
cloning and discovers that the cloned embryo produces viable stem cells
only after it is implanted in a woman's uterus for some time period and then
removed, this form of scientific research would be prohibited in Virginia
because such implantation could result in the birth of a human being.1
72
165. KASS & WILSON, supra note 121, at xvii.
166. BONNICKSEN, supra note 101, at 4.
167. See Heidi Forster & Emily Ramsey, The Law Meets Reproductive Technology: The
Prospect of Human Cloning, in CLONING AND THE FUTURE OF HUMAN EMBRYO RESEARCH,
supra note 87, at 217.
168. Id.
169. Id. at213.
170. Id.
171. HUMAN CLONING: SCIENCE, ETHICS, AND PUBLIC POLICY, supra note 1, at 120.
172. VA. CODE ANN. § 32.1-162.22 (Michie 2004).
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Although the researcher's intent would not be the birth of a child, the
relevant conduct could subject the individual to prosecution because the
statute does not require intent.173 Consequently, this would likely chill
research that the legislature attempted to exempt under the statute.
California's law against reproductive cloning is one example of a cloning
statute that is unintentionally overbroad. Under the law, "clone" means
"the practice of creating or attempting to create a human being by
transferring the nucleus from a human cell from whatever source into a
human egg cell from which the nucleus has been removed for the purpose
of [initiating a pregnancy].' 74 By including cells "from whatever source"
within the ban, the law forbids more than adult cloning - it also bans
embryo nuclear transplantation and fetal and adult cell nuclear
transplantation, as well as egg cell nuclear transplantation, which is not
cloning at all because no genome is replicated. 75 Perhaps in the end, a
scientist would not be liable under the law if he or she did not intend to
initiate a pregnancy, but the argument can be made that the potential
liability would chill activity that the legislature did not intend to prohibit.
A. The Scientific Debate about Recombinant DNA as Historical Analog
In the early 1970s, molecular biologists discovered how to remove bits of
genetic material (DNA) from various organisms and insert them into
bacteria in such a way that the transferred DNA became part of the
bacteria's genetic material. 176 The bacterial cells then duplicated and re-
duplicated the transferred DNA as they grew. 17 7 This novel "recombinant
DNA" methodology, which allowed researchers for the first time to isolate
and produce large quantities of specific genes, provided a uniquely
powerful tool for studying the mechanisms of genetics in organisms,
especially in the genetically complex cells of higher organisms.
178
Recombinants make it possible to study much more effectively the
mechanisms of inheritance and the regulation of gene function, questions
which had interested biologists for decades.
179
However, the new methodology also poses many potential dangers.
Most importantly, it raises a small possibility that highly virulent infective
agents could be released accidentally, leading to epidemic diseases of
173. Id.
174. CAL. HEALTH & SAFETY CODE § 24185 (West 2005) (emphasis added).
175. HUMAN CLONING: SCIENCE, ETHICS, AND PUBLIC POLICY, supra note 1, at 119.
176. THE RECOMBINANT DNA DEBATE, supra note 39, at 39.
177. Id. at 42.
178. Id. at 39.
179. Zander, supra note 41, at 11.
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unknown proportions.18 0 The hybrid organisms produced by recombinant
DNA research are novel, laboratory-created organisms that may never have
otherwise occurred in nature and may therefore be uniquely pathogenic to
humans or other organisms.' 8' Concern about these possible hazards
sparked an international debate on whether and how recombinant DNA
research should proceed. 82  Proponents of recombinant DNA research
hailed its potential applications to the treatment of genetic disease, the
manufacture of drugs, chemicals, and fuels, and the improvement of crop
plants and crop yields, among other areas, while opponents criticized the
research because of the potential hazards. 1
83
There are many similarities between the debate over recombinant DNA
and the current debate about cloning human embryos. First, both the
perceived benefits of the research, and its potential pitfalls, are highly
speculative. 184 Several philosophical and moral objections to recombinant
DNA research surfaced in the 1970s, objections which could easily be
raised today by opponents of therapeutic cloning.'85 Among these
objections were the following: (1) some kinds of knowledge, for example
nuclear fission, are dangerous and should not be sought by humankind; (2)
"[t]he fact that a particular kind of research can be done does not
automatically grant the right to do it"; and (3) in pursuing this research, we
begin to tamper with the nature of life itself.
86
Scientists themselves also recognized a more pressing issue: the small
possibility that new organisms with unexpected and perhaps dangerous
characteristics could be created in some types of recombinant DNA
experiments. 187 Several of the scientists whose work led to the
development of the cloning techniques wrote a letter to the scientific
community calling for a self-imposed moratorium on some recombinant
DNA research so that a careful risk assessment could be made. 8 8 The
National Institutes of Health (NIH) prepared guidelines to ensure the safety
of all research involving recombinant DNA molecules and the containment
180. A.M. Chakrabaty, Recombinant DNA: Areas of Potential Applications, in THE
RECOMBINANT DNA DEBATE, supra note 39, at 56.
181. Science for the People, Biological Social, and Political Issues in Genetic
Engineering, in THE RECOMBINANT DNA DEBATE, supra note 39, at 104.
182. THE RECOMBINANT DNA DEBATE, supra note 39, at xiii.
183. Chakrabaty, supra note 180, at 56.
184. Id.
185. Zander, supra note 41, at 8-9.
186. Id at 9.
187. David A. Jackson, Principles and Applications of Recombinant DNA Methodology,
in THE RECOMBINANT DNA DEBATE, supra note 39, at 39.
188. Id. at 39-40; Paul Berg et al., Potential Biohazards of Recombinant DNA
Molecules, 185 SCIENCE 303, 303 (1974).
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of organisms within the laboratory. 189 Under the guidelines, the riskiest
kinds of recombinant DNA research, experiments with high-risk pathogens
(referred to in the guidelines as "major actions"), are prohibited unless
approved through a restrictive process.' 90
Other recombinant DNA experiments are permitted, subject to certain
safeguards. For example, the cloning of viruses known to cause cancer in
animals is permitted under very restrictive conditions.' 9' The safeguards
require the use of specially designed physical containment facilities and
organisms specifically engineered to have a diminished ability to survive
outside the laboratory. 192  "Major actions" require approval by an
Institutional Biosafety Committee (IBC) and the NIH Director, review by
the Recombinant DNA Advisory Committee (RAG), and an opportunity for
formal agency notice-and-comment rulemaking.193
The guidelines are flexible and anticipate continuous review; a dozen
revisions since 1976 have taken into account new data and experience
accumulated through recombinant DNA research. 194  Moreover, the
guidelines provide an incentive for scientists to comply with them, rather
than a sanction for noncompliance. As a condition of NIH funding,
institutions must ensure that recombinant DNA research conducted at or
sponsored by the institution, irrespective of the source of funding, complies
with NIH Guidelines.1 95 "This is not only an attractive symbolic stance for
the law to take,"'196 but is also less expensive, since it requires a much less
sophisticated enforcement apparatus.
VI. LESS RESTRICTIVE POLICY ALTERNATIVES
Instead of criminalizing therapeutic cloning, legislatures should opt for
regulating therapeutic cloning. Although none of several alternative
approaches is perfect, any of them would avoid the problems associated
with the application of criminal sanctions to scientific research.
189. National Institutes of Health, NIH Guidelines for Research Involving Recombinant
DNA Molecules {hereinafter NIH Guidelines], Apr., 2002, available at
http://www4.od.nih.gov/oba/rac/guidelines_02/NIH GuidelinesApr 02.htm (last visited
Aug. 10, 2004).
190. Id.
191. Science for the People, supra note 181, at 101.
192. Dworkin, supra note 151, at 229-30.
193. NIH Guidelines, supra note 189.
194. Id.
195. Of course, the guidelines only control the behavior of those who need NIH funding.
Biotechnology companies and laboratories that seek no federal funds are left completely
unregulated. Science for the People, supra note 181, at 104.
196. Dworkin, supra note 151, at 230.
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A. Active support for therapeutic cloning
The United Kingdom was the first nation to pass a law allowing limited
human cloning for the purpose of creating stem cells from cloned human
embryos, and is currently the only country in Europe that clearly supports
therapeutic cloning. 197 While this is not a politically realistic goal in the
United States at the federal level, states are free to support therapeutic
cloning. California stands out as the innovator - for better or for worse -
on this issue. It is the first state to pass a law that affirmatively protects and
encourages embryonic stem cell research. 1
98
California allows stem cell research in the hope that it will lead to
breakthrough treatments for the millions of people who struggle with
crippling and degenerative diseases. 199 The United States and California are
leaders in biomedicine and biotechnology. Open and public research is
vital to California's biotechnology industry, and also to discovering new
treatments for diseases.200 The California bill permits "the derivation and
use of human embryonic stem cells, human embryonic germ cells, and
human adult stem cells from any source, including somatic cell nuclear
transplantation. 2 1 Any research that will use embryonic stem cells must
be reviewed and approved by a state ethics committee. 2
The California law encourages embryonic stem-cell research by offering
state funding, matching funds from private biotechnology companies and,
perhaps most importantly, creating an anxiety-free environment for
researchers.20 3 The statute also addresses alternative sources of embryos for
research: fertility practitioners shall give their patients appropriate
information to make voluntary decisions about their surplus embryos -
storing them, donating them to other couples, discarding them, or donating
them to research with written consent. 204 However, donors may not accept
any remuneration, except "reasonable payment for the removal, processing,
disposal, preservation, quality control, storage, transplantation, or
197. After Vigorous Debate Great Britain Becomes First Nation to Legalize Cloning
Stem Cells from Human Embryos, TRANSPLANT NEWS, Jan. 31, 2001.
198. CAL. HEALTH & SAFETY CODE §§ 125300, 125320 (West 2004) (providing for the
revocation of licenses issued to businesses for violations relating to human cloning, prohibits
the purchase or sale of ovum, zygote, embryo, or fetus for the purpose of cloning human
beings, and establishes civil penalties for violations).
199. CAL. HEALTH & SAFETY CODE § 125300.
200. Jessica J. Monachello, The Cloning for Biomedical Research Debate: Do the
Promises of Medical Advances Outweigh the Ethical Concerns?, 10 TULSA J. COMP. & INT'L
L. 591, 604 (2003).
201. Id.
202. CAL. HEALTH & SAFETY CODE § 125300.
203. CAL. HEALTH & SAFETY CODE § 125291.25.
204. CAL. HEALTH & SAFETY CODE § 125315.
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implantation. 2 °5 For now, the California bill allows scientists to pursue
their research. If Congress were to pass a pre-emptive ban on therapeutic
cloning, however, this laudable state experiment would be terminated.
B. The "aspirational" approach
Andrea Bonnicksen has proposed that even on the state level, legislatures
should refrain from enacting cloning laws, and instead, should seek to
encourage scientists to voluntarily comply with nationally developed
aspirational standards.20 6 Bonnicksen argues that instead of statutory bans,
there should be guidelines for action that leave room for adjustment as new
technologies emerge.0 7 She urges legislatures to craft "a cloning policy"
rather than draft "a cloning law.,
20 8
Bonnicksen made these arguments with an eye toward reproductive
cloning, but the arguments are even more persuasive for therapeutic
cloning. She suggests that regulatory policies can be better crafted over
time than can punitive laws.20 9 Cloning bans at either the state or federal
level may give a false sense of security to those who oppose cloning and
may remove some of the incentive to develop integrated, well-thought-out
cloning policies. 210 Moreover, working rules will provide a more effective
foundation for managing cloning developments than a targeted ban because
they develop through the medical and research community's achievements,
inquiry, and comment. l1
Once again, our experience with assisted reproductive technologies, such
as embryo freezing and gamete donation, provides a useful analogy that
underscores the value in refraining from restrictive statutes. Critics have
called for laws each time a novel reproductive technique is made available,
but legislative restraint has allowed professional associations and academics
to develop more comprehensive policies that address related issues, such as
informed consent, parent-child relationships, and safety.21 2 Doctor Wilmut
205. CAL. HEALTH & SAFETY CODE § 125320.
206. Andrea L. Bonnicksen, Crafting Cloning Policies, in HUMAN CLONING: SCIENCE,
ETHICS, AND PUBLIC POLICY, supra note 1, at 123. In contrast to a law, which is a binding
rule of conduct enacted by the government, aspirational documents present a framework for
making decisions based on shared values and goals. Such an approach attempts to articulate
a community consensus that guides behavior. The consensus that has developed in the
United States seems to be that reproductive cloning should be prohibited, at least until it is
safe, and federal funds should not be used for cloning and embryo research. Id. at 120-21.
207. Bonnicksen, supra note 1, at 123.
208. Id.
209. Id.
210. Id. at 128.
211. Id.
212. See ISLAT Working Group, ART into Science: Regulation of Fertility Techniques,
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and his colleagues have observed that people "tend to object as a matter of
course to any new, exotic technology that affects the human body. '213 The
innate suspicion eventually levels out and sometimes technology "that once
seemed outlandish, or even diabolical, is widely accepted as normal
,,214practice.
C. Regulation
Another option for legislative consideration is the establishment of a
regulatory apparatus to oversee therapeutic cloning and cloning research.
This hypothetical commission or agency could also be given authority over
new reproductive technologies, as well as other genetic technologies.
Administrative agencies are designed to make optimal use of experts in
technical areas and to use informal procedures to produce "flexible, easily
changed, realistic controls. 215 A regulatory agency could be established at
either the state or federal level. Great Britain's Human Fertilisation and
Embryology Authority, which regulates the safety and efficiency of embryo
research and assisted reproduction, is one model for a national regulatory
body.216 Susan Wolf suggests extending protection afforded to individuals
engaged in testing in the private sphere and regulating reproductive
technologies in conjunction with a central advisory body for novel
issues.2 17 Efforts by the President's Council on Bioethics and the National
Bioethics Advisory Commission (NBAC) to examine embryo research and
human cloning are at least an attempt to inject clinical and scientific
expertise into the legislative process. The National Institutes of Health
(NIH) Guidelines for recombinant DNA research are such an example.
However, in light of the American reluctance to oversee assisted
reproductive technologies, Congress is unlikely to erect a regulatory
framework. A potential middle ground would be to utilize an existing
agency, such as the Food and Drug Administration (FDA), for oversight.
The FDA has previously asserted that it has regulatory authority over
cloning. 21 s It has been argued, however that process-based oversight by the
government would be disastrous because regulatory compliance raises costs
281 SCIENCE 651-52 (July 31, 1998).
213. WILMUT ET AL., supra note 15, at 273.
214. Id. at 273-74.
215. Dworkin, supra note 151, at 229.
216. John A. Robertson, Human Cloning: Public Policy When Cloning Is Safe and
Effective, in HUMAN CLONING: SCIENCE, ETHICS, AND PUBLIC POLICY, supra note 1, at 145.
217. Susan M. Wolf, Ban Cloning? Why NBAC Is Wrong, 27 HASTINGS CENTER REP.
12, 12 (Sept.-Oct. 1997) (arguing that even reproductive cloning warrants regulation instead
of a ban).
218. BONNICKSEN, supra note 101, at 10.
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and increases paperwork. 219 As states reserve jurisdiction over matters of
health and family, perhaps they should step in and oversee therapeutic
cloning. To the limited extent that assisted reproductive technologies are
regulated at all, it is the states that already do so. As mentioned, California
law provides for review by a state ethics committee of all proposed
therapeutic cloning protocols. 220 The states also have an additional power
available to enforce regulatory standards: states can revoke medical
licenses.22'
At the very least, if Congress is determined to outlaw both reproductive
and therapeutic cloning, bans should include a sunset provision. In effect,
this would be like an enforced three-year moratorium on therapeutic
cloning. The NBAC endorsed a three to five year sunset provision so that
Congress could reevaluate "whether the prohibition continues to be
needed.,222  The President's Council on Bioethics also called for a
moratorium rather than a statutory ban.223 Such a solution would provide
flexibility and allow Congress to revisit the issue as society's needs change
over time. Legislation on the matter should also require that at some point
prior to the expiration of the sunset period, an appropriate oversight body
will valuate and report on the current status of nuclear transplantation
technology and on its pertinent ethical and social issues at that time.224
CONCLUSION
Although ethical issues underlying therapeutic cloning, as well as
arguments for and against its criminalization, are in fact quite distinct from
the debate about banning reproductive cloning, it appears that some of the
impetus behind the ban on therapeutic cloning is motivated by social
revulsion to the concept of human genetic clones. Yet there is no solid
evidence that allowing therapeutic cloning to proceed in the laboratory will
usher in an era of human reproductive cloning.
Statutory bans of therapeutic cloning are bad policy because they
eliminate the potentially revolutionary health benefits that are expected to
219. Susanne L. Huttner, Cloning and Public Policy: Biotechnology Lessons, in HUMAN
CLONING: SCIENCE, ETHICS, AND PUBLIC POLICY, supra note 1, at 157. The author argues
that the USDA and EPA experience has shown that government restrictions on technique or
process can discourage research and commercial investment by raising costs. id.
220. CAL. HEALTH & SAFETY CODE § 125300.
221. Forster & Ramsey, in CLONING AND THE FUTURE OF HUMAN EMBRYO RESEARCH,
supra note 87, at 211.
222. NAT'L BIOETHICS ADVISORY COMM'N REPORT, CLONING HUMAN BEINGS, available
at http://65.205.1.226/cloning/cloningreport.html.
223. The President's Council on Bioethics, supra note 6.
224. NAT'L BIOETHICS ADVISORY COMM'N REPORT, CLONING HUMAN BEINGS, supra
note 222.
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emerge from cloning research, especially with stem cells. Viewed from a
utilitarian perspective, these anticipated benefits outweigh the legitimate
ethical concern of destroying cloned embryos to create stem cells.
Restraints on scientific research are not preferred as a matter of policy, and
must be compelling enough to warrant implementation.
Opponents of therapeutic cloning have not met their burden of showing
that therapeutic cloning should be prohibited. Furthermore, the criminal
law is particularly ill-suited to the issue of therapeutic cloning. Problems of
enforcement, lack of deterrence, difficulties in crafting cloning laws, and
proper scope all point to the need for legislative restraint regarding nuclear
transplantation for biomedical research. Prior experiences with assisted
reproductive technologies and the recombinant DNA debate in the 1970s
demonstrate that restricting funding and issuing regulatory guidelines are
more effective ways for the legislature to shape the development of novel
scientific research.
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